A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect. Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday. “People living with obesity have an increased risk of cardiovascular disease, but to date, there are no […]
Wegovy could be good for more than just weight loss — the once-weekly semaglutide shot has been shown to reduce the risk of heart attack and stroke. The popular obesity medication successfully decreased the risk of major adverse cardiovascular events (MACEs) by 20% while observed over a five-year period, the drug’s manufacturer Novo Nordisk announced […]
The weightloss jab Wegovy can also reduce the risk of major cardiovascular events by 20% in people who are overweight or obese, the company behind the drug has said. Wegovy – which is not yet available in the UK – has been hailed a wonder drug for weightloss, with the National Institute for Health and […]
The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people with cardiovascular disease, the first to show a weight loss drug alone can have such protective effects.Novo Nordisk studied Wegovy against placebo in addition to […]
Novo Nordisk’s Wegovy, a weight loss drug currently in hot demand, now has data from a large, multi-year clinical trial showing the product also reduces the risk of major heart complications. The results support use of the drug in a wider swath of patients, and Novo Nordisk said it plans to seek regulatory approvals to […]
Share on PinterestResearchers say the more you walk, the better your health. Grant Faint/Getty Images Researchers are reporting that adding even an extra 500 to 1,000 steps per day to your exercise routine can improve your cardiovascular health. They add that walking more than 4,000 steps per day can reduce your risk of dying from […]
“People living with obesity have an increased risk of cardiovascular disease but to date, there are no approved weight management medications proven to deliver effective weight management while also reducing the risk of heart attack, stroke or cardiovascular death,” Martin Holst Lange, Novo Nordisk’s executive vice president for development, said in a statement announcing the […]
Diabetes drug semaglutide, marketed as Wegovy, could also reduce risk of cardiovascular events by 20%, its manufacturer has claimed. Novo Nordisk has announced headline findings from its SELECT trial, although they have not yet been published in a peer-reviewed journal. The manufacturer said the trial achieved its primary objective of demonstrating a statistically significant reduction […]
Wegovy, one of a new class of drugs used for weight loss, reduced the risk of serious cardiac events such as heart attacks by 20% in overweight and obese adults in a large trial, according to its manufacturer. Drugmaker Novo Nordisk on Tuesday reported the results of a new study that tracked more than 17,000 adults over […]
Image: The miniature human heart model could potentially transform drug testing and cardiovascular research (Photo courtesy of Tissue Dynamics) Cardiovascular ailments continue to be the primary cause of death worldwide. Now, a new multi-chambered, self-regulating miniature heart model offers a promising solution for improving survival and patient outcomes. In a groundbreaking development, a collaborative team […]